E-Media

Browse Database Titles

ALL   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others

Symbols:
- UCHC Access (Proxy Needed For Off-Campus Access)
- Free Access

Vascular cell signaling by membrane estrogen receptors - (Henry Stewart Talks)

Endothelium; Endothelial dysfunction; Estrogen-mediated cardiovascular protection and leukocyte-endothelial cell adhesion; Estrogen as a determinant of cardiovascular risk; Effects of estrogen on the cardiovascular system

Vascular cognitive impairment - (Henry Stewart Talks)

Vascular cognitive impairment; Concepts and criteria; Epidemiology; Pathogenesis; Leukoaraiosis and infarcts; Cognitive deficit; Typical patterns and screening; Imaging; Treatment; Disease modification and symptomatic

Vascular Tissue Engineering - (Henry Stewart Talks)

"Tissue engineering approaches; Different cell sources for a blood vessel substitute; Circulating endothelial progenitor cells: their characteristics, their use in a blood cell substitute and recruitment from the host circulating blood"

Vasoactive peptides and the blood-brain barrier - (Henry Stewart Talks)

"Blood-brain-barrier (BBB) functions, permeability pathways and transporters modulated by vasoactive peptides; The BBB as a source and target of vasocative peptides; Angiotensins; Bradykinin; Adrenomedullin; Calcitonin-gene related peptide; Endothelins"

VEGF Inhibitors for Anti-Angiogenic Therapy - (Henry Stewart Talks)

Antagonist monoclonal antibodies to VEGFR-3 – Mode of action of antagonist monoclonal antibodies – Functional properties of antagonist antibodies to VEGFR-3 – In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis

VEGF Inhibitors for Anti-Angiogenic Therapy - (Henry Stewart Talks)

Strategies to inhibit VEGFR signaling; Potential effects of inhibiting VEGF; Effects of anti-angiogenic therapy in preclinical models; Treatment of Human Xenograft Tumors With DC101; Combination Therapy with Anti-VEGFR-2 MAb and Gemcitabine

VEGF Receptor Family - (Henry Stewart Talks)

Vascular Endothelial Growth Factors (VEGF); Inhibition of VEGF action to control tumor angiogenesis; VEGFs and VEGF receptor tyrosine kinases; Structure of VEGF; Signaling through a receptor tyrosine kinase; Role of VEGFR-1 in angiogenesis

Viral Reservoirs, Latency and Mechanisms of HIV Persistence - (Henry Stewart Talks)

Viral dynamics in patients on antiretroviral drugs; CD4+ T-cells; Response of resting T-cells to AG; Establishment and maintenance of a latent reservoir; Dynamics of the latent pool; HIV evolution; HAART; Residual viremia and blips on patients on HAART

Virulence plasmids - (Henry Stewart Talks)

Definition and importance of virulence plasmids; Types of virulence plasmids; Toxin plasmids; The anthrax toxin plasmids; Clostridial toxin plasmids; Metabolic plasmids; Mycolactone biosynthesis by Mycobacterium ulcerans; Iron uptake by Vibrio anguillarum

Viruses and Cancer - (Henry Stewart Talks)

Oncogenic viruses of animals and humans give us insights into cancer in general; Specific genes involved in cancer such as oncogenes and tumor suppressor genes were first discovered through research on tumor viruses; Only a subset of viruses cause cancer

Visceral pain and visceral hypersensitivity - (Henry Stewart Talks)

"Visceral Pain; Diffuse, referred and typically difficult to manage; Visceral Hypersensitivity; Defining characteristic of functional gastrointestinal disorders; Contributed to by both peripheral and central mechanisms"

Visual Histology

Visual Histology streaming videos

Visualization of Transcription Factor Interactions in Living Cells - (Henry Stewart Talks)

Transcription regulatory proteins; Combinatorial control of gene expression; Visualization of transcription factor interactions and modifications in living cells; New methods development; Bimolecular fluorescence complementation (BiFC) assays

Visualizing and manipulating phosphoinositide and phospholipid signaling - (Henry Stewart Talks)

Making/using phosphoinositide phosphate (PIP) affinity probes; Effects of exogenous PIPs; Metabolically-stabilized PIPs; New tethering strategies; Signaling proteomics; Antibodies to PIPs; Visualizing phospholipase A and D activity with fluorogenic probes

Vitamin D and prostate cancer - (Henry Stewart Talks)

"Vitamin D actions: classical view and expanded view; Vitamin D metabolic pathways; Vitamin D and cancers; Vitamin D-deficiency hypothesis; Sunlight, vitamin D and prostate cancer risk; Importance of local production of calcitriol"

Vitamin D Endocrine System: Basics - (Henry Stewart Talks)

What is a vitamin?; What is a hormone?; Vitamin D biology fundamentals; Calcium homeostasis; Classical biological actions of vitamin D; Vitamin D and endocrine system; Key discoveries in the field; Kidney as an endocrine gland for hormone-D

Vitamin D Endocrine System: Mechanisms to Produce Biological Responses - (Henry Stewart Talks)

"Optimal ligand shapes; Modes of action of hormone-D; Shape of ligand for VDRNUC; Three dimensional shape of the VDR; Shape of ligand for DBP; DBP structure domains A, B, C; Shape of ligand for rapid responses; Steroid receptor superfamily"

Vitamin D Endocrine System: VDR Binding, Nutrition and Drugs Development - (Henry Stewart Talks)

VDR conformational ensemble; A vitamin D receptor ensemble model; X-ray crystal structure of the nuclear vitamin D receptor; VDR G- and A-pocket; Vitamin D nutrition for good health; Sources of vitamin D; How much vitamin D do we need?

Vitamin E regulation: mechanisms to control plasma atocopherol concentrations - (Henry Stewart Talks)

Factors that alter vitamin E status in humans; Oxidative stress and vitamin E; Vitamin E pharmacokinetics and metabolism; Xenobiotic metabolism

Voltage-Dependent Calcium Channels - (Henry Stewart Talks)

Introduction to voltage-gated calcium channels; Correlation of known structural features to function; Subtypes of calcium channels and their physiological correlates; Pharmacology of voltage-gated calcium channels